Hylak forte kvapky v liecbe atopického ekzému u detí
[Hylak Forte drops in the treatment of atopic eczema in children]
Language Slovak Country Czech Republic Media print
Document type English Abstract, Journal Article
PubMed
8477481
- MeSH
- Anti-Infective Agents administration & dosage MeSH
- Administration, Oral MeSH
- Dermatitis, Atopic drug therapy MeSH
- Child MeSH
- Humans MeSH
- Organic Chemicals MeSH
- Child, Preschool MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Names of Substances
- Anti-Infective Agents MeSH
- Hylak MeSH Browser
- Organic Chemicals MeSH
The authors describe a group of 14 children with atopic eczema where to common Hismanal or Zaditen treatment in tablet form Hylak forte drops were added (L. Merckle Co.). After two months treatment the authors observed regression of subjective and objective complaints in 10 children. As to the investigated immunological parameters, they observed normal phagocyte activity of granulocytes and in the majority of children a decline of circulating immune complexes. This creates prerequisite conditions for reducing the costs of treatment and for starting aimed specific hyposensitization.
